Literature DB >> 22424896

Response to 2009 pandemic influenza A H1N1 among public schools of Georgia, United States--fall 2009.

Muazzam Nasrullah1, Matthew J Breiding, Wendy Smith, Isaac McCullum, Karl Soetebier, Jennifer L Liang, Cherie Drenzek, Jeffrey R Miller, Daphne Copeland, Sabrina Walton, Susan Lance, Francisco Averhoff.   

Abstract

BACKGROUND: Little is known about the extent of implementation or the effectiveness of the Centers for Disease Control and Prevention's (CDC) recommended non-pharmaceutical interventions (NPIs) in schools to control the spread of 2009 pandemic influenza A H1N1 (pH1N1).
METHODS: A web-based, cross-sectional survey of all public K-12 schools in Georgia, USA was conducted about preparedness and response to pH1N1, and absenteeism and respiratory illness. Schools that reported ≥10% absenteeism and at least two times the normal level of respiratory illness in the same week were designated as having experienced significant respiratory illness and absenteeism (SRIA) during that week.
RESULTS: Of 2248 schools surveyed, 704 (31.3%) provided sufficient data to include in our analysis. Participating schools were spread throughout Georgia, USA and were similar to non-participating schools. Of 704 schools, 160 (22.7%) reported at least 1 week of SRIA. Most schools reported implementing the CDC recommendations for the control of pH1N1, and only two schools reported canceling or postponing activities. Schools that communicated with parents about influenza in the summer, had shorter school days, and were located in urban areas were less likely to experience SRIA.
CONCLUSIONS: Most Georgia schools in the United States adopted the CDC recommendations for pH1N1 mitigation and few disruptions of school activities were reported. Early and timely communication with parents, as well as shorter school days, may have been effective in limiting the effect of pH1N1 on schools. Published by Elsevier Ltd.

Entities:  

Mesh:

Year:  2012        PMID: 22424896     DOI: 10.1016/j.ijid.2012.01.010

Source DB:  PubMed          Journal:  Int J Infect Dis        ISSN: 1201-9712            Impact factor:   3.623


  6 in total

1.  Community Mitigation Guidelines to Prevent Pandemic Influenza - United States, 2017.

Authors:  Noreen Qualls; Alexandra Levitt; Neha Kanade; Narue Wright-Jegede; Stephanie Dopson; Matthew Biggerstaff; Carrie Reed; Amra Uzicanin
Journal:  MMWR Recomm Rep       Date:  2017-04-21

2.  A review of facilities management interventions to mitigate respiratory infections in existing buildings.

Authors:  Yan Zhang; Felix Kin Peng Hui; Colin Duffield; Ali Mohammed Saeed
Journal:  Build Environ       Date:  2022-06-28       Impact factor: 7.093

3.  Implementation of non-pharmaceutical interventions by New York City public schools to prevent 2009 influenza A.

Authors:  Simon G Agolory; Oxiris Barbot; Francisco Averhoff; Don Weiss; Elisha Wilson; Joseph Egger; Jeffery Miller; Ikechukwu Ogbuanu; Sabrina Walton; Emily Kahn
Journal:  PLoS One       Date:  2013-01-15       Impact factor: 3.240

4.  Knowledge, attitudes, and practices of nonpharmaceutical interventions following school dismissals during the 2009 Influenza A H1N1 pandemic in Michigan, United States.

Authors:  Jianrong Shi; Rashid Njai; Eden Wells; Jim Collins; Melinda Wilkins; Carrie Dooyema; Julie Sinclair; Hongjiang Gao; Jeanette J Rainey
Journal:  PLoS One       Date:  2014-04-18       Impact factor: 3.240

Review 5.  School practices to promote social distancing in K-12 schools: review of influenza pandemic policies and practices.

Authors:  Lori Uscher-Pines; Heather L Schwartz; Faruque Ahmed; Yenlik Zheteyeva; Erika Meza; Garrett Baker; Amra Uzicanin
Journal:  BMC Public Health       Date:  2018-03-27       Impact factor: 3.295

6.  Social distancing and testing as optimal strategies against the spread of COVID-19 in the Rio Grande Valley of Texas.

Authors:  Kristina P Vatcheva; Josef Sifuentes; Tamer Oraby; Jose Campo Maldonado; Timothy Huber; María Cristina Villalobos
Journal:  Infect Dis Model       Date:  2021-04-24
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.